SS18L1 is a transcriptional coactivator and component of the BAF chr20 remodeling complex that plays critical roles in neuronal development and gene regulation. As a paralog of SS18 1, SS18L1 functions in calcium-dependent transcriptional activation through the CREST-BRG1 complex, which orchestrates the release of repressor complexes and recruitment of coactivators like CREBBP in response to neuronal activity 2. SS18L1 is essential for activity-dependent dendritic growth and branching in cortical neurons, and mutations in SS18L1 have been associated with amyotrophic lateral sclerosis (ALS), including variants that impair dendritic outgrowth 2. Beyond neurology, SS18L1 can serve as an alternative fusion partner in malignancies: it has been identified in rare synovial sarcoma cases with SS18L1-SSX1 fusions, which retain diagnostic and clinical characteristics similar to canonical SS18-SSX tumors 345. Additionally, a novel MEF2C::SS18L1 fusion was identified in childhood acute B-lymphoblastic leukemia with high predicted oncogenic potential 6. SS18L1 involvement in chr20 remodeling also implicates it in broader cognitive function, with evidence suggesting its role in epigenetic regulation relevant to cognitive abilities 7.